225 related articles for article (PubMed ID: 23945350)
1. Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients.
Toan NL; Sy BT; Song le H; Luong HV; Binh NT; Binh VQ; Kandolf R; Velavan TP; Kremsner PG; Bock CT
BMC Infect Dis; 2013 Aug; 13():375. PubMed ID: 23945350
[TBL] [Abstract][Full Text] [Related]
2. The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children.
Duedu KO; Sagoe KW; Ayeh-Kumi PF; Affrim RB; Adiku T
Asian Pac J Trop Biomed; 2013 Feb; 3(2):129-39. PubMed ID: 23593592
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
5. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
6. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
[TBL] [Abstract][Full Text] [Related]
9. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities.
da Costa AC; Bendit I; de Oliveira ACS; Kallas EG; Sabino EC; Sanabani SS
Clin Microbiol Infect; 2013 Jan; 19(1):E31-E43. PubMed ID: 23167493
[TBL] [Abstract][Full Text] [Related]
10. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.
Würdinger M; Modrow S; Plentz A
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608818
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts.
Pedranti MS; Rodriguez-Lombardi G; Bracciaforte R; Romano N; Lujan P; Ricchi B; Mautino J; Adamo MP
J Med Microbiol; 2017 Dec; 66(12):1715-1721. PubMed ID: 29095139
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study on risk factors for infection with Parvovirus B19 and the association with anaemia in a febrile paediatric population in Ghana.
Herr W; Krumkamp R; Hogan B; Dekker D; Gyau K; Owusu-Dabo E; Sarpong N; Jaeger A; Loag W; Winter D; Akenten CW; Eibach D; Fickenscher H; Eis-Hübinger A; May J; Kreuels B
Sci Rep; 2020 Sep; 10(1):15695. PubMed ID: 32973247
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
15. Incidence and progression of Parvovirus B19 infection and molecular changes in circulating B19V strains in children with haematological malignancy: A follow up study.
Jain A; Jain P; Kumar A; Prakash S; Khan DN; Kant R
Infect Genet Evol; 2018 Jan; 57():177-184. PubMed ID: 29170063
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection.
Ingrassia F; Gadaleta A; Maggi P; Pastore G
BMC Infect Dis; 2010 Apr; 10():87. PubMed ID: 20359364
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic study of human parvovirus B19 infection in East China.
Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
[TBL] [Abstract][Full Text] [Related]
19. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors.
Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S
Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity of primate erythroparvovirus 1 between 2009 and 2016: First report from Turkey.
Aydin H; Timurkan MO; Aktas O
Microb Pathog; 2019 Apr; 129():131-135. PubMed ID: 30742946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
